# Saccharomyces Cerevisiae for Irritable Bowel Syndrome

> **NCT05149599** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ziauddin University** · enrollment: 30 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Saccharomyces cerevisiae

## Key facts

- **NCT ID:** NCT05149599
- **Lead sponsor:** Ziauddin University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05149599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05149599, "Saccharomyces Cerevisiae for Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05149599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*